| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Human Endometrium; Adenocarcinoma of endometrium, endometrioid, squamous features, focal from ORIGENE TECHNOLOGIES | CS511253 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, endometrioid, squamous features, focal from ORIGENE TECHNOLOGIES | CS514623 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, endometrioid, squamous features, focal from ORIGENE TECHNOLOGIES | CS805719 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, endometrioid, squamous features, focal from ORIGENE TECHNOLOGIES | CS514871 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, endometrioid, squamous features, focal from ORIGENE TECHNOLOGIES | CS515152 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, endometrioid, squamous features, focal from ORIGENE TECHNOLOGIES | CS516004 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, endometrioid, squamous features, focal from ORIGENE TECHNOLOGIES | CS516188 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, endometrioid, squamous features, focal from ORIGENE TECHNOLOGIES | CS516205 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, endometrioid, squamous features, focal from ORIGENE TECHNOLOGIES | CS522747 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, endometrioid, squamous features, focal from ORIGENE TECHNOLOGIES | CS528073 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, endometrioid, squamous features, focal from ORIGENE TECHNOLOGIES | CS600202 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, endometrioid, squamous features, focal from ORIGENE TECHNOLOGIES | CS620747 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, endometrioid, squamous features, focal from ORIGENE TECHNOLOGIES | CS601474 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, endometrioid, squamous features, focal from ORIGENE TECHNOLOGIES | CS621072 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, endometrioid, squamous features, focal from ORIGENE TECHNOLOGIES | CS623703 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, endometrioid, squamous features, focal from ORIGENE TECHNOLOGIES | CS630943 | 5x5um | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 4B (EIF4B) from ORIGENE TECHNOLOGIES | LY419945 | 100 ug | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, endometrioid, squamous features, focal from ORIGENE TECHNOLOGIES | CS601885 | 5x5um | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 2B, subunit 1 alpha, 26kDa (EIF2B1) from ORIGENE TECHNOLOGIES | LY419952 | 100 ug | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, endometrioid, squamous features, focal from ORIGENE TECHNOLOGIES | CS631074 | 5x5um | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 2B, subunit 4 delta, 67kDa (EIF2B4), transcript variant 1 from ORIGENE TECHNOLOGIES | LY406769 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 2B, subunit 4 delta, 67kDa (EIF2B4), transcript variant 3 from ORIGENE TECHNOLOGIES | LY414432 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 2B, subunit 2 beta, 39kDa (EIF2B2) from ORIGENE TECHNOLOGIES | LY402293 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa (EIF2B5) from ORIGENE TECHNOLOGIES | LY418363 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 2B, subunit 3 gamma, 58kDa (EIF2B3), transcript variant 1 from ORIGENE TECHNOLOGIES | LY412535 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 2B, subunit 3 gamma, 58kDa (EIF2B3), transcript variant 2 from ORIGENE TECHNOLOGIES | LY433030 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 2C, 1 (EIF2C1) from ORIGENE TECHNOLOGIES | LY402163 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 2C, 4 (EIF2C4) from ORIGENE TECHNOLOGIES | LY402604 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 2C, 2 (EIF2C2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY415922 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 2C, 3 (EIF2C3), transcript variant 2 from ORIGENE TECHNOLOGIES | LY430464 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 2C, 3 (EIF2C3), transcript variant 1 from ORIGENE TECHNOLOGIES | LY411021 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 2C, 2 (EIF2C2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY431620 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 4E binding protein 1 (EIF4EBP1) from ORIGENE TECHNOLOGIES | LY401322 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 4E binding protein 2 (EIF4EBP2) from ORIGENE TECHNOLOGIES | LY418216 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 4E binding protein 3 (EIF4EBP3) from ORIGENE TECHNOLOGIES | LY418472 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 4E (EIF4E), transcript variant 1 from ORIGENE TECHNOLOGIES | LY400723 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 2C, 3 (EIF2C3), transcript variant 2 from ORIGENE TECHNOLOGIES | LY406159 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 4E family member 2 (EIF4E2) from ORIGENE TECHNOLOGIES | LY401518 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 4E family member 3 (EIF4E3), transcript variant 2 from ORIGENE TECHNOLOGIES | LY406613 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 4E family member 3 (EIF4E3), transcript variant 4 from ORIGENE TECHNOLOGIES | LY427463 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 4E family member 3 (EIF4E3), transcript variant 3 from ORIGENE TECHNOLOGIES | LY427462 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 5 (EIF5), transcript variant 2 from ORIGENE TECHNOLOGIES | LY405302 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 1 (EIF1) from ORIGENE TECHNOLOGIES | LY401762 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 5 (EIF5), transcript variant 1 from ORIGENE TECHNOLOGIES | LY419615 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 5 (EIF5), transcript variant 2 from ORIGENE TECHNOLOGIES | LY430639 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 6 (EIF6), transcript variant 2 from ORIGENE TECHNOLOGIES | LY405776 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 4E nuclear import factor 1 (EIF4ENIF1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY412713 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 4 gamma, 3 (EIF4G3) from ORIGENE TECHNOLOGIES | LY418453 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 4E nuclear import factor 1 (EIF4ENIF1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY432079 | 100 ug | ORIGENE TECHNOLOGIES |
| Eukaryotic translation initiation factor 4 gamma, 1 (EIF4G1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY404962 | 100 ug | ORIGENE TECHNOLOGIES |